These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10604744)

  • 1. Prognostic value of cathepsin D in breast cancer.
    Stehle G; Wunder A; Hartung G; Sinn H; Heene DL
    Br J Cancer; 1999 Dec; 81(8):1427-8. PubMed ID: 10604744
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of cathepsin D in breast cancer.
    Westley BR; May FE
    Br J Cancer; 1999 Jan; 79(2):189-90. PubMed ID: 9888456
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cathepsin D in diagnosis of neoplastic diseases].
    Warwas M; Taurowska E
    Postepy Hig Med Dosw; 1993; 47(4):277-88. PubMed ID: 8309853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of cathepsin D in breast cancer].
    Rochefort H
    Rev Prat; 1990 Mar; 40(9):837-9. PubMed ID: 2320913
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of cathepsin B and D in physiologic and pathologic processes].
    Olszewska D; Drewa T; Makarewicz R; Drewa J; Woźniak A; Maciak R
    Pol Merkur Lekarski; 2001 Jan; 10(55):65-70. PubMed ID: 11320558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cathepsin D as a prognostic marker in breast cancer].
    Asculai E; Gopas J; Cohen Y
    Harefuah; 1996 Jun; 130(11):787-90. PubMed ID: 8794687
    [No Abstract]   [Full Text] [Related]  

  • 7. May cathepsin D immunoreactivity be used as a prognostic factor in endometrial carcinomas? A comparative immunohistochemical study.
    Saygili U; Koyuncuoglu M; Altunyurt S; Guclu S; Uslu T; Erten O
    Gynecol Oncol; 2001 Oct; 83(1):20-4. PubMed ID: 11585409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dilemma: does tissue expression of cathepsin D reflect tumor malignancy? The question: does the assay truly mirror cathepsin D mis-function in the tumor?
    Nicotra G; Castino R; Follo C; Peracchio C; Valente G; Isidoro C
    Cancer Biomark; 2010; 7(1):47-64. PubMed ID: 21045264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activity of cathepsin D in some neoplasms of the gastrointestinal tract].
    Kiluk M; Skrzydlewski Z; Kiluk A; Woroniecki A; Rucińska M; Kozłowski L
    Pol Merkur Lekarski; 1997 May; 2(11):307-8. PubMed ID: 9377676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
    Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
    Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical visualisation of cathepsin-D expression in breast cancer.
    Barthell E; Mylonas I; Shabani N; Kunze S; Kuhn C; Jeschke U; Friese K
    Anticancer Res; 2007; 27(4A):2035-9. PubMed ID: 17649818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin D expression in renal cell cancer-clinical implications.
    Merseburger AS; Hennenlotter J; Simon P; Ohneseit PA; Kuehs U; Kruck S; Koch E; Vogel U; Stenzl A; Kuczyk MA
    Eur Urol; 2005 Sep; 48(3):519-26. PubMed ID: 16115525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of cathepsin D in progression of neoplasms].
    Cybulski M; Berbeć H
    Postepy Biochem; 2001; 47(3):224-31. PubMed ID: 11908091
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
    Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
    Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells.
    Glondu M; Liaudet-Coopman E; Derocq D; Platet N; Rochefort H; Garcia M
    Oncogene; 2002 Aug; 21(33):5127-34. PubMed ID: 12140763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular prognostic factors for breast cancer metastasis and survival.
    Esteva FJ; Sahin AA; Cristofanilli M; Arun B; Hortobagyi GN
    Semin Radiat Oncol; 2002 Oct; 12(4):319-28. PubMed ID: 12382190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
    Scorilas A; Talieri M; Ardavanis A; Courtis N; Dimitriadis E; Yotis J; Tsiapalis CM; Trangas T
    Cancer Res; 2000 Oct; 60(19):5427-33. PubMed ID: 11034084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of cathepsin D in breast cancer. A long road to the clinic.
    Rochefort H
    Eur J Cancer; 1996 Jan; 32A(1):7-8. PubMed ID: 8695245
    [No Abstract]   [Full Text] [Related]  

  • 20. HER-2/neu overexpression in breast cancer: an immunohistochemical study including correlations with clinicopathologic parameters, p53 oncoprotein and cathepsin-D.
    Korkolis D; Ardavanis A; Yotis J; Kyroudi A; Gorgoulis V; Kittas C
    Anticancer Res; 2001; 21(3C):2207-12. PubMed ID: 11501848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.